TrialDiabetes technology & therapeutics2012

Noninferiority effects on glycemic control and β-cell function improvement in newly diagnosed type 2 diabetes patients: basal insulin monotherapy versus continuous subcutaneous insulin infusion treatment.

Longyi Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.